0001209191-14-067326.txt : 20141107 0001209191-14-067326.hdr.sgml : 20141107 20141107162652 ACCESSION NUMBER: 0001209191-14-067326 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141105 FILED AS OF DATE: 20141107 DATE AS OF CHANGE: 20141107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silva Paul M CENTRAL INDEX KEY: 0001446372 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 141205248 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-11-05 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001446372 Silva Paul M C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 SVP & Corp Controller Common Stock 2014-11-05 4 M 0 1687 45.11 A 18687 D Common Stock 2014-11-05 4 S 0 887 112.07 D 17800 D Common Stock 2014-11-05 4 S 0 700 112.93 D 17100 D Common Stock 2014-11-05 4 S 0 100 114.29 D 17000 D Common Stock 169 I 401(k) Stock Option (right to buy) 45.11 2014-11-05 4 M 0 1687 0.00 D 2023-02-04 Common Stock 1687 15188 D Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $112.07 (range $111.54 to $112.32). Open market sales reported on this line occurred at a weighted average price of $112.93 (range $112.60 to $113.49). The option vests in 16 quarterly installments from 02/05/2013. Omar White, Attorney-In-Fact 2014-11-07